Novo Nordisk Diabetes Patient Assistance Program

Novo Nordisk

The Novo Nordisk Patient Assistance Program (PAP) is based on our commitment to people living with diabetes. The Novo Nordisk PAP provides medication at no cost to those who qualify. Patients who are approved for the PAP may qualify to receive free diabetes medicine from Novo Nordisk for up to a year. There is no registration charge or monthly fee for participating.
If you are a patient, please visit or call 1-866-310-7549 to learn more about the program and eligibility. If you are a healthcare provider, please visit to learn more.
Contact Information
Novo Nordisk Patient Assistance Program
PO Box 370
Somerville, NJ 08876
Phone: 866-310-7549
Fax: 866-441-4190
How to Apply:
Please visit or click on one of the links below.



Patients must be a US Citizen or legal resident with a total household income at or below 400% of the federal poverty level. Patients cannot have any private prescription coverage, such as an HMO or PPO. Patients cannot have or qualify for Department of Veterans Affairs prescription benefits, any federal, state, or local programs such as Medicare or Medicaid. Exceptions include: Medicare Part D patients who have spent $1,000 on prescription medicine in the current calendar year
Product(s) covered by program:
Link to approved product list. Also listed below.
  • Tresiba® U-100 10mL vial, U-100 FlexTouch, U-200 FlexTouch
  • Levemir® 10 mL vial and FlexTouch
  • Fiasp® 10mL vial and FlexTouch
  • Novolog® 10mL vial and FlexPen®
  • Novolog® Mix 70/30 10mL vial and FlexPen®
  • Victoza®
  • Ozempic®
  • Xultophy® 100/3.6
  • NovoFine® 32G needles
  • NovoTwist® 32G needles
  • GlucaGen® HypoKit®